Researcher.Life Logo

The Lancet Gastroenterology and Hepatology : Impact Factor & More

eISSN: 2468-1253pISSN: 2468-1253

Key Metrics

CiteScore
31
Scite Index
0.86 5-Year SI
SNIP
6.95
Recommended pre-submission checks
Powered by Paperpal by Editage

The Lancet Gastroenterology and Hepatology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ELSEVIER INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2016
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in The Lancet Gastroenterology and Hepatology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in The Lancet Gastroenterology and Hepatology

Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trial.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Upfront medical or surgical treatment in Crohn's disease.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Wee, Poo, Snot: harnessing bodily functions to inspire budding scientists.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Adjuvant chemoradiotherapy versus completion total mesorectal excision after local excision for early rectal cancer (TESAR): a multicentre, randomised, controlled, phase 3, non-inferiority trial.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
The small interfering RNA imdusiran as single and multiple doses in healthy, randomised individuals and non-randomised individuals with chronic hepatitis B (AB-729-001): a phase 1a/b trial.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Effect of one or two cycles of dual immunotherapy with nivolumab and ipilimumab in patients with mismatch repair-deficient rectal cancer (RESET-R): interim results from a multicentre, single-arm, phase 2 trial.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Upfront medical or surgical treatment in Crohn's disease.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology
Wee, Poo, Snot: harnessing bodily functions to inspire budding scientists.
  • 1 Jul 2026
  • The lancet. Gastroenterology & hepatology

FAQs on The Lancet Gastroenterology and Hepatology